Evidence map›Paper›PMID 41582139›Full record

ArticleArthritis research & therapy2026

Rheumatoid arthritis and gout: a rare combination or overlooked coexistence?

Shaowei Li, Qianying Zhao, Xiao Cai, Xiaohong He, Shuxin Li, Zhihuang Chen, Song Wei, Wei Mao, Xueyin Chen, Yan Yu and 6 more

Abstract read
In one paragraph

Article in Arthritis research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shaowei LiThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China.
Qianying ZhaoThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China.
Xiao CaiThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China.
Xiaohong HeThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, Guangdong, 510120, China. wdtsxh521@126.com.
Shuxin LiThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China.
Zhihuang ChenDepartment of Chinese Medicine, General Hospital of Southern Theater Command, Guangzhou, Guangdong, 510010, China.
Song WeiDepartment of Chinese Medicine, General Hospital of Southern Theater Command, Guangzhou, Guangdong, 510010, China.
Wei MaoThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, Guangdong, 510120, China.
Xueyin ChenThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, Guangdong, 510120, China.
Yan YuThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China.
Tongtong WuThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China.
Linjie SongThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China.
Manli WuThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China.
Jingbei ZhangThe Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, China.
Xinfeng GuoThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, Guangdong, 510120, China. guoxinfeng@gzucm.edu.cn.
Lihong YangThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, Guangdong, 510120, China. lihongyang@gzucm.edu.cn.

Funding

Guangdong Provincial Key Laboratory for Prevention and Treatment of Refractory Chronic Diseases in Traditional Chinese Medicine 2023KT15525Guangzhou Science and Technology Bureau-Guangdong Provincial Hospital of Chinese Medicine Joint Project 2024A03J0718National Administration of Traditional Chinese Medicine's High-Level Construction of Key TCM Disciplines, Clinical Integration of TCM and Western Medicine (Rheumatology and Immunology) Project Zyyzdxk-2023162
6 · The paper itself

Abstract

backgroundRheumatoid arthritis (RA) and gout are traditionally considered distinct diseases with differing pathogenic mechanisms, making their coexistence controversial. Emerging evidence suggests this overlap may be underestimated. This study aimed to evaluate their epidemiological association, genetic causality, and intersecting molecular features.

methodsEpidemiological analyses used National Health and Nutrition Examination Survey (NHANES; 2007 ~ 2018, n = 19,705) data. Propensity score matching and weighted multivariate logistic regression assessed gout prevalence, temporal trends, and risk factors in RA. Restricted cubic spline (RCS) analysis examined nonlinear serum urate (SUA)-gout associations within RA. Mendelian randomization (MR) analyses based on genome-wide association study (GWAS) data evaluated causal effects of overall RA, Seronegative RA (SNRA), and Seropositive RA (SPRA) on gout and SUA, with multiple testing controlled by Bonferroni correction. Transcriptomic analyses from the Gene Expression Omnibus (GEO) used differential expression and weighted gene co-expression network analysis (WGCNA). Results were integrated with disease-related genes from the Comparative Toxicogenomics Database (CTD), Online Mendelian Inheritance in Man (OMIM), and GeneCards databases for enrichment and pathway analyses.

resultsNHANES data indicated higher gout prevalence among RA patients compared to matched controls (10.3% vs. 4.8%, P < 0.001), with an increasing trend over time (P = 0.006). Weighted logistic regression supported RA as an independent risk factor for gout (OR: 2.67; 95% CI: 1.95 to 3.67; P < 0.001). RCS analysis revealed a nonlinear SUA-gout association in RA (P < 0.05). MR supported a causal effect of RA on gout, strongest for SNRA (OR = 1.132; 95% CI: 1.044 to 1.227; P = 0.003) after Bonferroni correction, whereas no effect was found for SPRA on gout or for RA, SNRA, and SPRA on SUA. Bioinformatics analysis identified 207 shared RA-gout genes enriched in interferon signaling, immune activation, and antiviral defense pathways, highlighting five hub genes (RSAD2, DDX60, IFIT1, IFIT3, XAF1) central to a convergent interferon-driven mechanism.

conclusionsRA and gout may overlap more than previously recognized, with stronger genetic evidence in SNRA. No causal effect on SUA suggests the link may not primarily involve urate pathways. Transcriptomic overlap in interferon signaling indicates potential molecular intersections, warranting further investigation.

Indexed as

Arthritis, RheumatoidGoutFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMaleMendelian Randomization AnalysisMiddle AgedNutrition SurveysPrevalenceRisk FactorsBioinformatics analysisGoutMendelian randomization analysisNational Health and Nutrition Examination SurveyRheumatoid arthritis

Identifiers

PMID41582139
PMCPMC12918516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.